OSCR

Growth Hormone-Insulin-like Growth Factor Axis and GDF-15 in Critical Illness: Implications for Survival Stratification.

Overview

Authors: Ioannis Ilias1, Chrysi Keskinidou2, Georgios Poupouzas2, Vasileios Issaris2, Nikolaos S. Lotsios2, Efthymia Botoula3, Marinella Tzanela3, Dimitra A. Vassiliadi3, Stelios Kokkoris2, Charikleia S. Vrettou2, Alice G. Vassiliou2, Ioanna Dimopoulou2
  1. Department of Endocrinology, Hippokration Hospital, 11527 Athens, Greece
  2. 1st Department of Critical Care Medicine, Evangelismos Hospital, School of Medicine, National and Kapodistrian University of Athens, 10676 Athens, Greece; (C.K.); (G.P.); (V.I.); (N.S.L.); (S.K.); (C.S.V.); (A.G.V.); (I.D.)
  3. Department of Endocrinology, Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, 10676 Athens, Greece; (E.B.); (M.T.); (D.A.V.)
Journal: Life (Basel, Switzerland), volume 16, issue 8, article 1245
Dates: received 24 June 2026; accepted 25 July 2026; published online 27 July 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3390/life16081245 · PMID 42652933 · PMCID PMC13514936 · OpenAlex W7171453382
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: human (organism), clinical / translational (subfield)
Methods: Connectivity, Statistics, Machine learning
Keywords: critical illness, GH–IGF axis, GDF-15, IGFBP-2, biomarker intercorrelation, partial correlation, hierarchical clustering, ICU mortality, pilot study, STROBE
Topic: GDF15 and Related Biomarkers (Rheumatology, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 26 references in the paper

Abstract

Background: The growth hormone (GH)–insulin-like growth factor (IGF) axis is profoundly dysregulated in critical illness. GDF-15 and individual IGF-binding proteins (IGFBPs) have separately been proposed as prognostic biomarkers, but to our knowledge, no prior study has simultaneously characterized all major GH–IGF axis components and GDF-15 in the same critically ill cohort, precluding assessment of their joint intercorrelation structure. Aim: To provide the first simultaneous characterization of the intercorrelation structure among ten GH–IGF axis components and GDF-15 in a single ICU cohort, testing whether this structure is robust to adjustment for illness severity; and, secondarily, to describe admission discriminatory performance relative to APACHE II and SOFA. Methods: This was a prospective observational pilot study of 43 critically ill adults with admission (T01) measurement of ten GH–IGF axis biomarkers and longitudinal follow-up to day 15. Spearman correlations and hierarchical clustering characterized the admission intercorrelation structure; partial correlations adjusting for APACHE II and SOFA, and bootstrap confidence intervals, assessed robustness. Secondary analyses included the examination of admission discrimination (ROC/AUC), a leave-one-out cross-validated combined model, and longitudinal trajectories. All analyses were exploratory, hypothesis-generating, and unadjusted for multiple comparisons unless stated. Results: Hierarchical clustering identified a coherent cluster comprising GDF-15, IGFBP-1, IGFBP-2, and growth hormone-binding protein (GHBP), distinct from classical GH-resistance markers (GHR vs. healthy controls, GHR vs. admission) and from GH, IGF-1, acid-labile subunit (ALS), and IGFBP-3. Within this cluster, GDF-15 correlated with IGFBP-1 (ρ = 0.65, 95% bootstrap CI 0.44–0.78), IGFBP-2 (ρ = 0.50, CI 0.19–0.71), and GHBP (ρ = 0.47, CI 0.20–0.68); GDF-15 showed no correlation with classical GH-resistance markers. These correlations were essentially unchanged after adjusting for APACHE II or SOFA (partial ρ within 0.03–0.16 of unadjusted values), indicating the structure is not attributable to shared confounding by illness severity. This robustness extended to further adjustment for IL-6, age, BMI, and mechanical-ventilation duration, and results from all 45 pairwise T01 correlations were re-examined with Benjamini–Hochberg false-discovery-rate correction (9 of 11 nominally significant pairs retained q < 0.05). However, the GDF-15–GHBP correlation, unlike the GDF-15–IGFBP-1/IGFBP-2 correlations, attenuated substantially after adjustment for IL-6 and was not consistent across a brain-injury/non-brain-injury subgroup sensitivity analysis, indicating this specific link is less specific than the others. In secondary exploratory analyses, GDF-15 had the highest individual admission AUC (0.74) among biomarkers but was substantially outperformed by APACHE II (AUC 0.90) and SOFA (AUC 0.81); a combined GDF-15 + IGFBP-2 model did not improve on GDF-15 alone. Conclusions: This study identifies a severity-independent intercorrelation structure linking GDF-15 to inhibitory IGFBPs, distinct from classical GH-resistance signaling, in critically ill patients. Although the findings do not support any clinical application at this stage, further study in adequately powered, multicenter cohorts can be contemplated.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

Anonymized data used in this study are available at Zenodo: https://doi.org/10.5281/zenodo.20844938. During the preparation of this manuscript, the authors used Claude Sonnet 4.6 (Anthropic, https://claude.ai/, accessed on 1 May 2026) and Gemini 2.5 Flash (Google, https://gemini.google.com/, accessed on 1 May 2026) for statistical code assistance, artwork, and language/syntax corrections. The authors have reviewed and edited the output and take full responsibility for the content of this publication.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Funding: added Stavros Niarchos Foundation

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 12 authors, 10 keywords, 26 references.

Cite

This paper

Ilias, I., Keskinidou, C., Poupouzas, G., Issaris, V., Lotsios, N. S., Botoula, E., Tzanela, M., Vassiliadi, D. A., Kokkoris, S., Vrettou, C. S., Vassiliou, A. G., & Dimopoulou, I. (2026). Growth Hormone-Insulin-like Growth Factor Axis and GDF-15 in Critical Illness: Implications for Survival Stratification. Life (Basel, Switzerland), 16(8), 1245. https://doi.org/10.3390/life16081245

BibTeX

@article{ilias2026growth,
author = {Ilias, Ioannis and Keskinidou, Chrysi and Poupouzas, Georgios and Issaris, Vasileios and Lotsios, Nikolaos S. and Botoula, Efthymia and Tzanela, Marinella and Vassiliadi, Dimitra A. and Kokkoris, Stelios and Vrettou, Charikleia S. and Vassiliou, Alice G. and Dimopoulou, Ioanna},
title = {{Growth Hormone-Insulin-like Growth Factor Axis and GDF-15 in Critical Illness: Implications for Survival Stratification}},
journal = {Life (Basel, Switzerland)},
year = {2026},
month = jul,
volume = {16},
number = {8},
pages = {1245},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2075-1729},
doi = {10.3390/life16081245},
url = {https://doi.org/10.3390/life16081245},
pmid = {42652933},
pmcid = {PMC13514936}
}

RIS

TY - JOUR
AU - Ilias, Ioannis
AU - Keskinidou, Chrysi
AU - Poupouzas, Georgios
AU - Issaris, Vasileios
AU - Lotsios, Nikolaos S.
AU - Botoula, Efthymia
AU - Tzanela, Marinella
AU - Vassiliadi, Dimitra A.
AU - Kokkoris, Stelios
AU - Vrettou, Charikleia S.
AU - Vassiliou, Alice G.
AU - Dimopoulou, Ioanna
TI - Growth Hormone-Insulin-like Growth Factor Axis and GDF-15 in Critical Illness: Implications for Survival Stratification
T2 - Life (Basel, Switzerland)
J2 - Life (Basel)
PY - 2026
DA - 2026/07/27
VL - 16
IS - 8
SP - 1245
SN - 2075-1729
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/life16081245
UR - https://doi.org/10.3390/life16081245
LA - en
ER -

CSL-JSON

{
"id": "10.3390/life16081245",
"type": "article-journal",
"title": "Growth Hormone-Insulin-like Growth Factor Axis and GDF-15 in Critical Illness: Implications for Survival Stratification",
"container-title": "Life (Basel, Switzerland)",
"author": [
{
"family": "Ilias",
"given": "Ioannis"
},
{
"family": "Keskinidou",
"given": "Chrysi"
},
{
"family": "Poupouzas",
"given": "Georgios"
},
{
"family": "Issaris",
"given": "Vasileios"
},
{
"family": "Lotsios",
"given": "Nikolaos S."
},
{
"family": "Botoula",
"given": "Efthymia"
},
{
"family": "Tzanela",
"given": "Marinella"
},
{
"family": "Vassiliadi",
"given": "Dimitra A."
},
{
"family": "Kokkoris",
"given": "Stelios"
},
{
"family": "Vrettou",
"given": "Charikleia S."
},
{
"family": "Vassiliou",
"given": "Alice G."
},
{
"family": "Dimopoulou",
"given": "Ioanna"
}
],
"container-title-short": "Life (Basel)",
"volume": "16",
"issue": "8",
"page": "1245",
"DOI": "10.3390/life16081245",
"PMID": "42652933",
"PMCID": "PMC13514936",
"ISSN": "2075-1729",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/life16081245",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
27
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1007/s00415-026-14134-z
What do ALS motor phenotypes measure? A population-based decomposition of their prognostic dimensions.
Journal: Journal of neurology
In common: clinical / translational, 1 reference
[2] doi:10.1038/s41531-026-01408-6 [code]
A stacked multi-classifier for multi-modal data fusion in transcranial sonography-based Parkinson's disease assessment.
Journal: NPJ Parkinson's disease
In common: clinical / translational, 1 reference
[3] doi:10.1186/s13073-026-01650-w [code]
DNA methylation biomarkers-based pan-cancer classifier: predictive modeling for cancer classification.
Journal: Genome medicine
In common: clinical / translational, 1 reference
[4] doi:10.1038/s41598-026-50791-w [code]
Hybrid Vi+ECNN framework for advanced ADHD diagnostic accuracy in medical imaging.
Journal: Scientific reports
In common: clinical / translational, 1 reference
[5] doi:10.1038/s43856-026-01817-x [code]
Visual prompt engineering for multimodal and irregularly sampled medical data.
Journal: Communications medicine
In common: clinical / translational, 1 reference
[6] doi:10.3389/fneur.2026.1849021
Early pharmacologic venous thromboembolism prophylaxis and in-hospital mortality in ICU patients with intracerebral hemorrhage: a landmark, propensity-weighted cohort study.
Journal: Frontiers in neurology
In common: clinical / translational, 1 reference
[7] doi:10.1002/hsr2.72247
Epidemiology of Traumatic Brain Injury in Medicare Beneficiaries over the Last Decade: A Retrospective Observational Study.
Journal: Health science reports
In common: clinical / translational, 1 reference
[8] doi:10.1002/ccs3.70041
The suppressor of cytokine signaling 3 regulates glioma stem cell maintenance and immune microenvironment through signal transducer and activator of transcription 3 signaling.
Journal: Journal of cell communication and signaling
In common: 1 reference
[9] doi:10.1371/journal.pone.0349740
Longitudinal changes in intracortical excitability during Ramadan diurnal intermittent fasting: A paired-pulse transcranial magnetic stimulation study.
Journal: PloS one
In common: 1 reference
[10] doi:10.3389/fped.2026.1912111 [code]
Serial amplitude-integrated electroencephalography trajectories and brain-injury-associated functional immaturity in extremely preterm infants.
Journal: Frontiers in pediatrics
In common: 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.